Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK to use Affymetrix technology to identify genetic variations
“This agreement demonstrates the power of genetics in the drug discovery and development process,” said Greg Yap, vice president of DNA Products at Affymetrix. “We anticipate that a
“This agreement demonstrates the power of genetics in the drug discovery and development process,” said Greg Yap, vice president of DNA Products at Affymetrix. “We anticipate that a
In 2002, Humira was approved to treat patients with moderately to severely active rheumatoid arthritis (RA), who have had insufficient response to one or more disease-modifying anti-rheumatic drugs.
The designation covers all 25 countries that comprise the European Union. Similar orphan drug status was previously granted to Xechem by the FDA. “Obtaining Orphan Drug status for
INNO-105 is a naturally occurring peptide that has recently demonstrated anti-tumor activity in a phase I pancreatic cancer study. Innovive Pharmaceuticals licensed the worldwide rights to the drug
Each of this year’s Specialized Center of Research (SCOR) recipients will receive $1.25 million per year for five years, a total of $6.25 million. In addition, the society
The trial’s independent safety and efficacy monitoring committee (SEMC) observed a safety concern from trial data collected thus far and is in the process of evaluating the entire
Amiloride and spironolactone are diuretics or ‘water pills’ that have been available for many years but no longer get much attention from prescribing physicians. A study by Indiana
The results of the study, published in the October issue of Cancer Research, demonstrate that Calando’s proprietary delivery technology can deliver short interfering RNA (siRNA) to targeted cancer
Using Affymetrix GeneChip technology including the GeneChip Human Mapping 500K Array Set, Perlegen scientists will assay up to 675,000 unique genetic variations (also called single nucleotide polymorphisms or
The company also said that in an effort to advance Oxycyte through the clinical development process and secure phase II data rapidly, it has temporarily suspended patient enrollment